Literature DB >> 15261178

Interleukin-6 and B-type natriuretic peptide are independent predictors for worsening of heart failure in patients with progressive congestive heart failure.

Marianne Gwechenberger1, Martin Hülsmann, Rudolf Berger, Senta Graf, Christoph Springer, Brigitte Stanek, Richard Pacher.   

Abstract

BACKGROUND: Neurohormones and cytokines have been associated with poor prognosis in patients with congestive heart failure. However, direct comparisons between them are rare and the best predictor for worsening of heart failure remains to be elucidated. The aim of the study was to identify independent predictors for worsening of heart failure.
METHODS: We studied 100 patients with congestive heart failure (LVEF <or=25%). Serum levels of interleukin-6 (IL-6), tumor necrosis factor (TNF)-alpha, aminoterminal atrial natriuretic peptide (N-ANP), B-type natriuretic peptide (BNP), aminoterminal B-type natriuretic peptide (N-BNP), norepinephrine (NE) and big endothelin (big ET) were measured at entry into the study. Univariate and stepwise multivariate regression analyses were performed to compare variables and clinical parameters. The end-point was defined as worsening of heart failure.
RESULTS: During follow-up (mean 378 days), 30 patients reached the defined end-point. Univariate risk factors of worsening of heart failure were IL-6 (p = 0.0001), log BNP (p = 0.0001), log N-ANP (p = 0.0259), big ET (p = 0.0032), log N-BNP (p = 0.0495), NE (p = 0.0013) and LVEF (p = 0.0498). Multivariate regression analysis identified IL-6 as the strongest independent predictive value for worsening of heart failure (p = 0.0001), followed by log BNP (p = 0.0002). Mean IL-6 levels were 1.76 +/- 1.73 in stable patients and 4.62 +/- 7.98 pg/ml in patients who developed worsening of heart failure. Using a cut-off value of 1.66 pg/ml for IL-6 Kaplan-Meier freedom from worsening, heart failure was significantly higher in patients below this cut-off point compared with those above (p = 0.0002).
CONCLUSIONS: IL-6 and BNP independently predict worsening of heart failure. A single measurement could help to identify patients at high risk for worsening of heart failure and these individuals should be monitored more closely.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15261178     DOI: 10.1016/j.healun.2003.07.023

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  6 in total

Review 1.  Reappraisal of Inflammatory Biomarkers in Heart Failure.

Authors:  Thanat Chaikijurajai; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2020-02

2.  Altered desmosomal proteins in granulomatous myocarditis and potential pathogenic links to arrhythmogenic right ventricular cardiomyopathy.

Authors:  Angeliki Asimaki; Harikrishna Tandri; Elizabeth R Duffy; Jeffrey R Winterfield; Shannon Mackey-Bojack; Maria M Picken; Leslie T Cooper; David J Wilber; Frank I Marcus; Cristina Basso; Gaetano Thiene; Adalena Tsatsopoulou; Nikos Protonotarios; William G Stevenson; William J McKenna; Shiva Gautam; Daniel G Remick; Hugh Calkins; Jeffrey E Saffitz
Journal:  Circ Arrhythm Electrophysiol       Date:  2011-08-22

Review 3.  Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure : a clinical review.

Authors:  David R Buvat de Virginy
Journal:  Heart Fail Rev       Date:  2006-12       Impact factor: 4.214

Review 4.  Biomarkers in heart failure: a clinical review.

Authors:  J Paul Rocchiccioli; John J V McMurray; Anna F Dominiczak
Journal:  Heart Fail Rev       Date:  2008-12-03       Impact factor: 4.214

5.  Are there differences in acute phase inflammation markers regarding the type of heart failure?

Authors:  Ignacio J Sánchez-Lázaro; Luis Almenar-Bonet; Edelmiro Reganon-Salvador; Virtudes Vila-Liante; Vicenta Martínez-Sales; Luis Martínez-Dolz; Jaime Agüero-Ramón-Llin; Antonio Salvador-Sanz
Journal:  Heart Int       Date:  2011-10-21

6.  Microparticles in patients undergoing transcatheter aortic valve implantation (TAVI).

Authors:  Christian Jung; Michael Lichtenauer; Hans-Reiner Figulla; Bernhard Wernly; Bjoern Goebel; Martin Foerster; Christoph Edlinger; Alexander Lauten
Journal:  Heart Vessels       Date:  2016-08-03       Impact factor: 2.037

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.